Erudio Healtherudio.com
Sponsor
ETOP IBCSG Partners Foundation trials: what clinicians said in public
No HCP commentary report on a trial sponsored by ETOP IBCSG Partners Foundation yet. Erudio has found public clinician commentary on 5 clinical trials sponsored by ETOP IBCSG Partners Foundation, including ADEPPT, ADOPT-lung, BEAT-meso and PREcoopERA. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (ETOP IBCSG Partners Foundation). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| BEAT-meso NCT03762018 · ETOP IBCSG Partners Foundation DeepView → | first-line advanced malignant pleural mesothelioma | Phase 3 | Deep | View | |||
| PREcoopERA NCT05896566 · ETOP IBCSG Partners Foundation DeepView → | premenopausal ER-positive/HER2-negative early breast cancer | Phase 2 | Deep | View | |||
| ADOPT-lung NCT06284317 · ETOP IBCSG Partners Foundation StandardView → | stage IIB-IIIB (N2) resectable NSCLC | Phase 3 | Standard | View | |||
| ADEPPT NCT05673187 · ETOP IBCSG Partners Foundation FocusedView → | KRASG12C-mutant NSCLC, elderly or poor performance status | Phase 2 | Focused | View | |||
| NICOLAS NCT02434081 · ETOP IBCSG Partners Foundation FocusedView → | Not given | Phase 2 | Focused | View | |||